InsidersTradesSigma
Zydus Lifesciences: management transactions · India · SEBI (PIT + SAST)
Browse the full management transaction log of Zydus Lifesciences, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €1,117.6bn. The latest transaction was disclosed on 26 May 2026 (Acquisition). Among the most active insiders: Samar Babubhai Patel. All data is accessible without an account.
1
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Zydus Lifesciences Hold (neutral), based on 30 analysts. Average price target: ₹1,066.50.
5Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,157 of 20,531 companies
62.1
score / 100
Value45
Quality79
Growthn/a
FCF yld-0.5%
Earn yld4.5%
EV/EBITDA14.7x
ROE18%
Gross mgn73%
Net mgn19%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal. See the method
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 26 May 2026
Declarations1 total
10,000 shares0Equity SharesOff MarketSEBI:3177fd2efbc1476513435085ac9c7935208f2e06
Ideal exit: 20 Feb 2027 (T+270)
1 of 1 declaration